A team of researchers at the Computer Science and Artificial Intelligence Laboratory at the Massachusetts Institute of Technology are developing artificial intelligence that they believe will greatly reduce the number of false positives in breast cancer detection when women undergo mammograms. The research team is made up of scientists from MIT, Harvard Medical School, and Massachusetts General Hospital.
False positives result from lesions that appear suspicious on mammograms and these lesions often have abnormal cells when tested by biopsy. As a result, patients undergo surgery to remove the lesions. But in 90 percent of the cases the lesions are benign. The goal of the research is to develop a program that will be able to determine whether the lesions are benign before surgery is considered. If successful, the artificial intelligence program could reduce the number of women who undergo unnecessary surgery.
In early tests, the artificial intelligence program correctly identified 97 percent of the breast cancers as malignant and reduced the number of benign surgeries by 30 percent.


A paper about the research effort, “High-Risk Breast Lesions: A Machine Learning Model to Predict Pathologic Upgrade and Reduce Unnecessary Surgical Excision,” was published on the website of the journal Radiology. It may be accessed here.


